Target intelligence / Profile preview

Beta-lactamase class A and class C (Class A β-lactamase (often abbreviated as Class A BL) and class C β-lactamase (Class C BL); there is no single unified abbreviation for both classes together.)

Target
Class A β-lactamase (often abbreviated as Class A BL) and class C β-lactamase (Class C BL); there is no single unified abbreviation for both classes together.
Molecular classification
Enzyme, Hydrolase, Antibiotic resistance enzyme, Serine hydrolase (A and C both use active site serine), Beta-lactamase
01

Overview

Class A and class C beta-lactamases are two major molecular classes of enzymes produced by bacteria that confer resistance to beta-lactam antibiotics (including penicillins, cephalosporins, and related drugs). Both are serine hydrolases: they utilize an active site serine to break the characteristic four-membered beta-lactam ring of these antibiotics, disabling their antibacterial activity. Class A beta-lactamases include enzymes such as TEM, SHV, and CTX-M, many of which are plasmid-encoded, spread easily, and may confer extended-spectrum resistance (ESBLs). They are often inhibited by clavulanic acid but can evolve inhibitor resistance. Class C beta-lactamases (often called AmpC enzymes) are typically chromosomally encoded cephalosporinases that confer resistance primarily to cephalosporins and are often not inhibited by traditional beta-lactamase inhibitors. Both enzyme classes use a conserved mechanism involving acylation of a serine residue, followed by hydrolysis of the beta-lactam ring, and play a critical role in global antibiotic resistance in clinically important Gram-negative bacteria.

Other names
Class A serine β-lactamaseClass C serine β-lactamaseSerine β-lactamase (encompassing A, C, and D)Penicillinase (for some Class A enzymes)Cephalosporinase (for many Class C enzymes)ESBL (Extended-spectrum beta-lactamase, often for Class A variants like TEM, SHV, CTX-M)
02

Mechanism of action

Hydrolysis of beta-lactam ring: The enzyme attacks the amide bond of the beta-lactam ring, breaking antibiotic structure and inactivating antibacterial activity. Serine-based catalysis: Both A and C use a nucleophilic serine (Ser70) for acylation and breakdown of beta-lactam antibiotics.

03

Biological functions

Antibiotic hydrolysisAntibiotic resistanceInactivation of beta-lactam antibiotics
04

Disease associations

Infection (bacterial): Major contributor to bacterial resistance in infectious diseases, particularly in Gram-negative bacteriaIndirectly associated with treatment failure for infections due to antibiotic resistance
05

Safety considerations

Therapeutic challenge: Rapid emergence of resistance renders many antibiotics ineffectiveCross-resistance: Transferable enzymes via plasmids can make outbreaks difficult to controlDetection limitations: Some class C enzymes (AmpC) are not inhibited by common beta-lactamase inhibitors, leading to potential misdiagnosis of resistance
06

Interacting drugs

Beta-lactam antibiotics: Penicillins, cephalosporins, monobactams, carbapenems (hydrolyzed/inactivated by these enzymes, to varying extents)

1 more in the full profile.

07

Biomarkers

Presence of class A or class C beta-lactamase genes/proteins (via PCR, immunoassay, or activity assays) can serve as a biomarker for antibiotic resistance in clinical isolatesSubstrate profile: Resistance to penicillins and cephalosporins, respectively, often indicates the presence of class A or C beta-lactamases

Beyond the preview

Go deeper on Beta-lactamase class A and class C (Class A β-lactamase (often abbreviated as Class A BL) and class C β-lactamase (Class C BL); there is no single unified abbreviation for both classes together.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase class A and class C (Class A β-lactamase (often abbreviated as Class A BL) and class C β-lactamase (Class C BL); there is no single unified abbreviation for both classes together.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call